Warnke, C., Leussink, V. I., Goebels, N., Aktas, O., Boyko, A., Kieseier, B. C., & Hartung, H. (2012). Cladribine as a therapeutic option in multiple sclerosis. Clinical immunology (Orlando, Fla.), 142(1), 68. https://doi.org/10.1016/j.clim.2011.05.009
Style de citation ChicagoWarnke, Clemens, Verena I. Leussink, Norbert Goebels, Orhan Aktas, Alexey Boyko, Bernd C. Kieseier, et Hans-Peter Hartung. "Cladribine as a Therapeutic Option in Multiple Sclerosis." Clinical Immunology (Orlando, Fla.) 142, no. 1 (2012): 68. https://dx.doi.org/10.1016/j.clim.2011.05.009.
Style de citation MLAWarnke, Clemens, et al. "Cladribine as a Therapeutic Option in Multiple Sclerosis." Clinical Immunology (Orlando, Fla.), vol. 142, no. 1, 2012, p. 68.
Attention : ces citations peuvent ne pas être correctes à 100%.